These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31048502)

  • 1. Randomised controlled trial of fractionated and unfractionated prednisolone regimens for dogs with immune-mediated haemolytic anaemia.
    Swann JW; Szladovits B; Threlfall AJ; Garden OA; Chang YM; Church DB; Glanemann B
    Vet Rec; 2019 Jun; 184(25):771. PubMed ID: 31048502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
    Piek CJ; van Spil WE; Junius G; Dekker A
    BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.
    Swann JW; Skelly BJ
    J Small Anim Pract; 2011 Jul; 52(7):353-8. PubMed ID: 21668886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary autoimmune haemolytic anaemia in the dog.
    Bennett D; Finnett SL; Nash AS; Kirkham D
    Vet Rec; 1981 Aug; 109(8):150-3. PubMed ID: 7324359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
    Oggier D; Tomsa K; Mevissen M; Glaus T
    Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A suspected case of a multiple autoimmune syndrome in a poodle dog.
    Lim D; Jin Y; Son Y; Oh T; Bae S
    Vet Med Sci; 2022 Mar; 8(2):431-436. PubMed ID: 35137556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs.
    Helmond SE; Polzin DJ; Armstrong PJ; Finke M; Smith SA
    J Vet Intern Med; 2010; 24(3):597-605. PubMed ID: 20384956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Three months of prednisolone is enough treatment for IHA].
    Haneveld JK
    Tijdschr Diergeneeskd; 2011 Sep; 136(9):654-5. PubMed ID: 21939018
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
    Wang A; Smith JR; Creevy KE
    J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic (acquired) haemolytic anaemia in the dog.
    Mackenzie CP
    Vet Rec; 1969 Sep; 85(13):356-61. PubMed ID: 5388388
    [No Abstract]   [Full Text] [Related]  

  • 12. C
    Goggs R; Behling-Kelly E
    BMC Vet Res; 2019 Dec; 15(1):475. PubMed ID: 31888626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisolone and danazol for treatment of immune-mediated anemia, thrombocytopenia, and ineffective erythroid regeneration in a dog.
    Holloway SA; Meyer DJ; Mannella C
    J Am Vet Med Assoc; 1990 Oct; 197(8):1045-8. PubMed ID: 2243038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Alternaria infectoria infection in a dog in association with therapeutic immunosuppression for the management of immune-mediated haemolytic anaemia.
    Dedola C; Stuart AP; Ridyard AE; Else RW; van den Broek AH; Choi JS; de Hoog GS; Thoday KL
    Vet Dermatol; 2010 Dec; 21(6):626-34. PubMed ID: 20500496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia.
    Bestwick JP; Sharman M; Whitley NT; Kisielewicz C; Skelly BJ; Tappin S; Kellett-Gregory L; Seth M
    J Vet Intern Med; 2022 Jan; 36(1):78-85. PubMed ID: 34779044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.
    Swann JW; Tayler S; Hall H; Sparrow R; Skelly BJ; Glanemann B
    PLoS One; 2021; 16(9):e0257700. PubMed ID: 34543364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immune-mediated haemolytic anaemia: a retrospective long-term study in 61 dogs.
    Weingart C; Thielemann D; Kohn B
    Aust Vet J; 2019 Dec; 97(12):483-489. PubMed ID: 31454853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
    Panek CM; Nakamura RK; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Reimer ME; Troy GC; Warnick LD
    J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.
    Morassi A; Bianco D; Park E; Nakamura RK; White GA
    J Vet Emerg Crit Care (San Antonio); 2016 Jul; 26(4):488-94. PubMed ID: 27074368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.